A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe.
第一作者:
Jean-Jacques,Body
第一单位:
Department of Medicine, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
作者:
关键词
AAP, abiraterone acetate with prednisone/prednisoloneAQA, Analgesic Quantification AlgorithmBMs, bone metastasesBPI, Brief Pain InventoryBTA, bone-targeted agentBone metastasesBone painBone-targeted agentsDSP, Disease Specific ProgrammeEQ-5D-3L, 5-dimension 3-level EuroQol questionnaireEU5, France, Germany, Italy, Spain and the UKFACT-P, Functional Assessment of Cancer Therapy – Prostate questionnaireONJ, osteonecrosis of the jawPRF, Patient Record FormPRO, patient-reported outcomePSCF, Patient Self-Completion FormQoL, quality of lifeSRE, skeletal-related eventmCRPC, metastatic castration-resistant prostate cancer
DOI
10.1016/j.jbo.2018.100212
PMID
30627511
发布时间
2024-07-14
- 浏览1
Journal of bone oncology
2019年14卷
100212页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文